Glasgow Prognostic Score (GPS and mGPS) Calculator


Combine CRP and albumin into the GPS and mGPS, two inflammation-based prognostic scores used in cancer.

Enter the values and click Calculate.

أدخل القيم:
النتائج:

About this calculator

The Glasgow Prognostic Score uses two routine blood tests to measure the systemic inflammatory response. The modified score gives no points for low albumin on its own.

What you need

  • C-reactive protein (CRP) in mg/L - the inflammation marker.
  • Serum albumin in g/L - from the same metabolic panel.

Both are routine blood tests in cancer care; the score combines them into a 0-2 prognostic grade.

Formula

GPS: CRP above 10 mg/L scores 1 and albumin below 35 g/L scores 1. mGPS: CRP 10 or less scores 0; CRP above 10 with albumin 35 or more scores 1; CRP above 10 with albumin below 35 scores 2.

How to read the result

GPS: 0 = both CRP 10 or less and albumin 35 or more; 1 = one of them abnormal; 2 = both abnormal (CRP over 10 and albumin under 35). Modified GPS (mGPS): 0 = CRP 10 or less regardless of albumin; 1 = CRP over 10 with albumin 35 or more; 2 = CRP over 10 with albumin under 35. Higher scores are associated with progressively worse survival across many cancer types in the literature - a population-level prognostic signal, not an individual prediction.

Worked example

CRP 25 mg/L and albumin 30 g/L: GPS 2 and mGPS 2.

Common mistakes

  • Mixing units - the cutoffs assume CRP in mg/L and albumin in g/L; convert g/dL albumin by ×10.
  • Scoring during an intercurrent infection, which can spike CRP and inflate the grade.
  • Applying it outside the cancer context it was derived in.

Limitations

A prognostic marker for groups of patients, not a guide to treatment for one person. CRP and albumin are affected by infection and other inflammation.

Frequently asked questions

GPS or mGPS?
The modified version is now more widely used because isolated hypoalbuminaemia without inflammation is rare and adds little; both are reported here.
What does the score change?
It stratifies prognosis in studies and can inform treatment-intensity discussions; it does not by itself change treatment.

Reference

  • Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 2003;89(6):1028-1030. doi:10.1038/sj.bjc.6601242
  • McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 2013;39(5):534-540.

Disclaimer. Medical information only. This calculator is an educational aid for clinicians and students. It does not give medical advice, diagnosis or treatment, and it does not replace clinical judgment. Check results against the original source and local protocols before using them in patient care.